PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

NCT01585649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Ewing Family of Tumors, Rhabdomyosarcoma

Interventions

DRUG: Lipegfilgrastim

Sponsor

Merckle GmbH